Fahn, Stanley

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,536

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature

Alzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

Cited by 3,498

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease

Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 2,366

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNeurology and Historical Studies

Cited by 859

Huntington disease: Clinical care and evaluation

Shoulson, I., & Fahn, S. (1979) · Neurology

Genetic Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis Research

Cited by 746

DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., et al. (2007) · Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 548

The metabolic topography of parkinsonism

Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski, S., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 455

Reliability of a new scale for essential tremor

Elble, R., Comella, C., Fahn, S., Hallett, M., Jankovic, J., Juncos, J. L., LeWitt, P., Lyons, K., Ondo, W., Pahwa, R., et al. (2012) · Movement Disorders

Deep Brain Stimulation and Movement DisordersMotor Control and Adaptation

Cited by 244

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease

Fahn, S. (1992) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsCoenzyme Q10 studies and effects

Cited by 211

Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes

Ma, Y., Tang, C., Chaly, T., Greene, P., Breeze, R., Fahn, S., Freed, C., Dhawan, V., & Eidelberg, D. (2010) · Journal of Nuclear Medicine

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 185

SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease

Alcalay, R. N., Mallett, V., Vanderperre, B., Tavassoly, O., Dauvilliers, Y., Wu, R. Y. J., Ruskey, J. A., Leblond, C. S., Ambalavanan, A., Laurent, S. B., et al. (2019) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders Research

Cited by 110

Benefits and Risks of Pharmacological Treatments for Essential Tremor

Lyons, K. E., Pahwa, R., Comella, C. L., Eisa, M. S., Elble, R. J., Fahn, S., Jankovic, J., Juncos, J. L., Koller, W. C., Ondo, W. G., et al. (2003) · Drug Safety

Deep Brain Stimulation and Movement DisordersBotulinum Toxin and Related Neurological Disorders

Cited by 103

How do you treat motor complications in Parkinson's disease: medicine, surgery, or both?

Fahn, S. (2009) · Annals of Neurology

Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments

Cited by 66

Clinicopathological characteristics of freezing of gait in autopsy‐confirmed Parkinson's disease

Virmani, T., Moskowitz, C. B., Vonsattel, J., & Fahn, S. (2015) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsBalance, Gait, and Falls Prevention

Cited by 56

Diagnosing Parkinson's disease using videotaped neurological examinations: Validity and factors that contribute to incorrect diagnoses

Louis, E. D., Levy, G., Côte, L. J., Mejia, H., Fahn, S., & Marder, K. (2002) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 41

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease

Senkevich, K., Zorca, C. E., Dworkind, A., Rudakou, U., Somerville, E., Yu, E., Ermolaev, A., Nikanorova, D., Ahmad, J., Ruskey, J. A., et al. (2023) · Brain

Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments

Cited by 40

Psychogenic movement disorders

Fahn, S., Jankovic, J., & Hallett, M. (2011) · Principles and Practice of Movement Disorders

Psychosomatic Disorders and Their TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 37